Novel compound heterozygous mutations of POLR3A revealed by whole-exome sequencing in a patient with hypomyelination

Brain Dev. 2014 Apr;36(4):315-21. doi: 10.1016/j.braindev.2013.04.011. Epub 2013 May 18.

Abstract

Objective: Congenital white matter disorders are a heterogeneous group of hypomyelination disorders affecting the white matter of the brain. Recently, mutations in the genes encoding the subunits of RNA polymerase III (Pol III), POLR3A and POLR3B, have been identified as new genetic causes for hypomyelinating disorders.

Method: Whole-exome sequencing was applied to identify responsible gene mutations in a 29-year-old female patient showing hypomyelination of unknown cause. To investigate the pathological mechanism underlying the hypomyelination in this patient, the expression level of 7SL RNA, a transcriptional target of Pol III, was analyzed in cultured skin fibroblasts derived from the patient with POLR3A mutations.

Results: Novel compound heterozygous mutations of POLR3A were identified in the patient, who started to show cerebellar signs at 3 years, lost ambulation at 7 years, and became bedridden at 18 years. Brain magnetic resonance imaging showed severe volume loss in the brainstem, the cerebellum, and the white matter associated with hypomyelination. In addition to hypodontia and hypogonadism, she showed many pituitary hormone-related deficiencies. The expression level of 7SL RNA in cultured skin fibroblasts derived from this patient showed no significant abnormality.

Conclusion: The many pituitary hormone-related deficiencies identified in this patient may be an essential finding for the Pol III-related leukodystrophies spectrum. Further investigation is needed for a better understanding of the disease mechanism.

Keywords: Hypomyelination; Hypomyelination with hypodontia and hypogonadotropic hypogonadism (4H) syndrome; Leukodystrophy; POLR3A; RNA polymerase III (Pol III); Whole-exome sequencing.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Brain / pathology
  • Cells, Cultured
  • DNA Mutational Analysis / methods
  • Exome / genetics
  • Female
  • Fibroblasts / metabolism
  • Hereditary Central Nervous System Demyelinating Diseases / genetics*
  • Hereditary Central Nervous System Demyelinating Diseases / metabolism
  • Hereditary Central Nervous System Demyelinating Diseases / pathology
  • Humans
  • Magnetic Resonance Imaging
  • Mutation
  • RNA Polymerase III / genetics*
  • RNA Polymerase III / metabolism
  • RNA, Small Cytoplasmic / metabolism
  • Signal Recognition Particle / metabolism
  • Skin / metabolism

Substances

  • 7SL RNA
  • RNA, Small Cytoplasmic
  • Signal Recognition Particle
  • POLR3A protein, human
  • RNA Polymerase III